Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Parenthood in Long-Term Survivors After CHOEP Treatment for Aggressive Lymphoma Is Not Significantly Impaired in Comparison to the General Population. Results From the Mabthera International Trial (MInT) and the DSHNHL NHLB1 Study

Julia Meissner, MD, Sascha Dietrich, MD, Marita Ziepert, PhD, Evelyn Kuhnt, Tanja Rixecker, Mathias Witzens-Harig, MD, Michael Pfreundschuh, MD, Anthony D Ho, MD

Blood (2012) 120 (21): 3649.

https://doi.org/10.1182/blood.V120.21.3649.3649

Published: 2012

Journal Articles

Fertility and Gonadal Function After Treatment of Early Unfavorable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG)

Karolin Behringer, MD, Indra Thielen, MD, Horst Mueller, Helen Goergen, Angelika Eibl, Johannes Rosenbrock, Teresa Halbsguth, MD, Katrin S. Reiners, PhD, Volker Diehl, MD, Andreas Engert, MD, Peter Borchmann, MD

Blood (2011) 118 (21): 432.

https://doi.org/10.1182/blood.V118.21.432.432

Published: 2011

Journal Articles

Six Cycles of BEACOPP Tailored Based on Interim Scintigraphy Provide Favorable Outcome for Patients with Standard and Advanced Risk Hodgkin Lymphoma and Female Fertility Is Preserved: Results of a 10-Year Follow-up

Eldad J Dann, MD, Zeev Blumenfeld, MD, Rachel Bar-Shalom, MD, Irit Avivi, MD, Menachem Ben-Shachar, MD, Odelia Goor, MD, Diana Libster, MD, Diana Gaitini, MD, Jacob M. Rowe, MD, Ron Epelbaum, MD

Blood (2011) 118 (21): 1564.

https://doi.org/10.1182/blood.V118.21.1564.1564

Published: 2011

Journal Articles

Secondary MDS/AML In Hodgkin Lymphoma Patients Treated within German Hodgkin Study Group (GHSG) Clinical Trials After Introduction of the BEACOPP Protocol

Dennis A. Eichenauer, Heinz Haverkamp, Karolin Behringer, Teresa Halbsguth, MD, Michael Fuchs, Volker Diehl, Peter Borchmann, Andreas Engert

Blood (2010) 116 (21): 2682.

https://doi.org/10.1182/blood.V116.21.2682.2682

Published: 2010

Journal Articles

Therapy Related APL (tAPL). Prospective Analysis of Etiological Factors In Recent Cases, and Comparison with De Novo Cases

Blood (2010) 116 (21): 2171.

https://doi.org/10.1182/blood.V116.21.2171.2171

Published: 2010

Journal Articles

Leuprolide Acetate (GnRH Agonist) to Enhance Immune Function Post-Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Richard Champlin, Eva C. Guinan, MD, Lee M. Nadler, MD, Patricia McAdams, RN, Lisa Brennan, RN, Christine Barbon, MS, Ping Jiang, MS, Kristof Chwalisz, MD, PhD, Cynthia Mattia-Goldberg, Karim Sajwani, MS, Richard Boyd, MD, Peter F. Thall, PhD, Robertson Parkman, MD

Blood (2010) 116 (21): 4292.

https://doi.org/10.1182/blood.V116.21.4292.4292

Published: 2010

Journal Articles

For Standard and High-Risk Patients with Hodgkin Lymphoma Six Cycles of Tailored BEACOPP, Based On Interim Scintigraphy, Are Effective and Female Fertility Is Preserved.

Eldad Dann, MD, Rachel Bar-Shalom, MD, Ada Tamir, PhD, Menachem Ben-Shachar, MD, Irit Avivi, MD, Tsila Zuckerman, MD, Nuhad Haddad, MD, Hanna Rosenbaum, MD, Riva Fineman, MD, Odelia Goor, MD, Diana Libster, MD, Zeev Blumenfeld, MD, Jacob M. Rowe, MD, Ron Epelbaum, MD

Blood (2009) 114 (22): 1552.

https://doi.org/10.1182/blood.V114.22.1552.1552

Published: 2009

Journal Articles

No Reduction of Ovarian Failure with the Use of GnRH-Analogues or Oral Contraceptives in Young Women Treated with Escalated BEACOPP for Advanced-Stage Hodgkin Lymphoma (HL). Final Results of the PROFE Trial, German Hodgkin Study Group (GHSG).

Karolin Behringer, Ludwig Wildt, Horst Mueller, Helmut-Werner Ott, Susanne Hofer, Volker Diehl, Beate van den Hoonard, Andreas Engert, Peter Borchmann

Blood (2009) 114 (22): 3710.

https://doi.org/10.1182/blood.V114.22.3710.3710

Published: 2009

Journal Articles

The Effect of Temporary Elevated 17 B Estradiol (E2) Levels On the Coagulation System as Measured by D-Dimer in Women Undergoing in Vitro Fertilization.

Tamar Sokal-Arnon, MD, Aliza Cassel, PhD, Evelyne Shabad, MD, Zofnat Wiener-Megnazi, MD, Ron Auslender, MD, Martha Dirnfeld, MD, Miriam Quitt, MD

Blood (2009) 114 (22): 4004.

https://doi.org/10.1182/blood.V114.22.4004.4004

Published: 2009

NARROW

Parenthood in Long-Term Survivors After CHOEP Treatment for Aggressive Lymphoma Is Not Significantly Impaired in Comparison to the General Population. Results From the Mabthera International Trial (MInT) and the DSHNHL NHLB1 Study

Fertility and Gonadal Function After Treatment of Early Unfavorable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG)

Six Cycles of BEACOPP Tailored Based on Interim Scintigraphy Provide Favorable Outcome for Patients with Standard and Advanced Risk Hodgkin Lymphoma and Female Fertility Is Preserved: Results of a 10-Year Follow-up

Secondary MDS/AML In Hodgkin Lymphoma Patients Treated within German Hodgkin Study Group (GHSG) Clinical Trials After Introduction of the BEACOPP Protocol

Therapy Related APL (tAPL). Prospective Analysis of Etiological Factors In Recent Cases, and Comparison with De Novo Cases

Leuprolide Acetate (GnRH Agonist) to Enhance Immune Function Post-Autologous Hematopoietic Stem Cell Transplantation (HSCT)

For Standard and High-Risk Patients with Hodgkin Lymphoma Six Cycles of Tailored BEACOPP, Based On Interim Scintigraphy, Are Effective and Female Fertility Is Preserved.

No Reduction of Ovarian Failure with the Use of GnRH-Analogues or Oral Contraceptives in Young Women Treated with Escalated BEACOPP for Advanced-Stage Hodgkin Lymphoma (HL). Final Results of the PROFE Trial, German Hodgkin Study Group (GHSG).

The Effect of Temporary Elevated 17 B Estradiol (E2) Levels On the Coagulation System as Measured by D-Dimer in Women Undergoing in Vitro Fertilization.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only